Concordance between TP53 alterations in blood and tissue: impact of time interval, biopsy site, cancer type and circulating tumor DNA burden
We examined the impact of spatial, temporal, histologic, and quantitative factors on concordance between TP53 alterations in tissue DNA vs in circulating tumor DNA (ctDNA). Four hundred and thirty‐three patients underwent next‐generation sequencing (NGS) in which both tissue and blood samples were e...
Main Authors: | Cheyennedra C. Bieg‐Bourne, Ryosuke Okamura, Razelle Kurzrock |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-06-01
|
Series: | Molecular Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1002/1878-0261.12672 |
Similar Items
-
TP53 mutations in circulating tumor DNA in advanced epidermal growth factor receptor-mutant lung adenocarcinoma patients treated with gefitinib
by: Ruofei Yu, et al.
Published: (2021-09-01) -
Circulating Tumor Cells: From the Laboratory to the Cancer Clinic
by: Ruchi Agashe, et al.
Published: (2020-08-01) -
The Polemic Diagnostic Role of <i>TP53</i> Mutations in Liquid Biopsies from Breast, Colon and Lung Cancers
by: M. Carmen Garrido-Navas, et al.
Published: (2020-11-01) -
Signed in Blood: Circulating Tumor DNA in Cancer Diagnosis, Treatment and Screening
by: Jacob J. Adashek, et al.
Published: (2021-07-01) -
The TP53 fertility network
by: Diego d'Avila Paskulin, et al.
Published: (2012-01-01)